CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 119 enrolled
Drug / intervention
Interview +4 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04989556
NCT04989556N/AActive
CompareCT.gov

Technology-Enhanced Palliative Care for Cancer Patients

M.D. Anderson Cancer Center·interventional·Posted Aug 4, 2021·Updated Oct 14, 2025

In Brief

A clinical study evaluating Interview, Palliative Therapy, and 2 other interventions for Advanced Malignant Solid Neoplasm. Active but no longer recruiting, targeting 119 participants across 1 site.

Detailed Summary

This trial investigates technology-enhanced palliative care for patients in phase I trials with cancer that has spread to other places in the body (advanced). The goal of this study is to learn if the technology-enhanced palliative care symptom-monitoring program, when combined with in-person clinic visits and standard remote care visits (by phone or video call), helps increase quality of life and care for patients with advanced cancer participating in phase 1 immunotherapy trials.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Malignant Solid Neoplasm
CountriesUnited States
Collaborators--

Timeline

N/AActiveOverdue
202120222023202420252026
First PostedAug 4, 2021
Enrollment StartAug 20, 2020
Primary CompletionMay 7, 2026
TodayJul 1, 2026
Enrollment to primary: 5.7 yearsPosted 4.9 years ago

Interventions

Interviewother

Participate in interview

Palliative Therapyother

Receive standard symptom management by palliative care team

Palliative Therapyother

Receive provider initiated remote contact

Quality-of-Life Assessmentother

Ancillary studies

Questionnaire Administrationother

Complete questionnaire